AES Clean Technology, a leading provider of high-performance cleanroom facilities within the pharmaceutical and bio-pharmaceutical industry, has announced a $14.2 million investment to open a new manufacturing facility located in Manheim Borough, Lancaster County, Pennsylvania.

The new state-of-the-art facility will see 97 full-time jobs created and will serve as a manufacturing hub for its modular cleanroom systems. As part of the project, AES will carry out building renovations, purchase the latest production technologies to manufacture its cleanroom products, and train new employees. 

This new manufacturing site will be phased into operation in the coming year and will compliment AES’ existing manufacturing capabilities in Suwanee, GA, and will further expand AES’ production capabilities to match industry growth, particularly from those clients responsible for the manufacturing of COVID-19 treatments and advanced bio-therapeutics.

Grant Merrill, CEO of AES Clean Technology commented, ”We are proud to expand upon our 35-year presence in the Commonwealth of Pennsylvania as we continue the mission of helping our pharmaceutical and biotechnology clients save lives through the therapies that they manufacture inside our cleanroom facilities.”

“It’s an important factor to us, and our customers, that we directly control the manufacturing of these critical cleanroom systems. This investment is evidence of our ongoing commitment to controlling all aspects of the supply chain as we bring cleanroom facilities to life for our clients.”

The company will retain the existing 95 jobs at its headquarters in Montgomery County and current manufacturing operations in Suwanee, GA.

AES Cleanroom Technology

AES Cleanroom Technology is a leading modular cleanroom facilities provider for pharmaceutical and biotechnology customers engaging in clinical research through commercial manufacturing, addressing unmet medical needs in areas such as immunotherapy, diabetes, cancer, and various other debilitating conditions. AES has been a valued partner in Operation Warp Speed as its cleanroom facilities have supported the manufacturing of COVID vaccines, antibody therapeutics, and diagnostic devices.